US 11,744,967 B2
Intranasal delivery devices
Shunji Haruta, Kagoshima (JP)
Assigned to SHIN NIPPON BIOMEDICAL LABORATORIES, LTD., Kagoshima (JP)
Filed by SHIN NIPPON BIOMEDICAL LABORATORIES, LTD., Kagoshima (JP)
Filed on Sep. 21, 2018, as Appl. No. 16/137,852.
Claims priority of provisional application 62/563,244, filed on Sep. 26, 2017.
Prior Publication US 2019/0091424 A1, Mar. 28, 2019
Int. Cl. A61M 15/08 (2006.01); B05B 11/06 (2006.01); A61M 11/02 (2006.01); B05B 11/00 (2006.01); A61M 15/00 (2006.01); A61M 16/20 (2006.01); B05B 11/10 (2023.01)
CPC A61M 15/08 (2013.01) [B05B 11/061 (2013.01); A61M 11/02 (2013.01); A61M 15/0025 (2014.02); A61M 16/208 (2013.01); A61M 2202/064 (2013.01); A61M 2205/075 (2013.01); A61M 2210/0618 (2013.01); B05B 11/062 (2013.01); B05B 11/1052 (2023.01)] 24 Claims
OG exemplary drawing
 
1. A device for delivering a therapeutic formulation, wherein the device comprises:
a nozzle having a reservoir disposed within the nozzle,
a valve comprising a conical section,
a hollow retainer, and
a manual air pump,
wherein the reservoir has the therapeutic formulation disposed therein,
wherein the conical section protrudes into a lower end of the reservoir and an outer portion of the conical section contacts the therapeutic formulation,
wherein the manual air pump is operably linked to an upstream end of the nozzle and a downstream end of the retainer,
wherein the valve is at least partially fit into the reservoir, and has one or more contacting points with the retainer that immobilizes the valve, and
wherein the valve prevents movement of the therapeutic formulation into the manual air pump and regulates a flow of air.